In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Hosted on MSN
Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives
Wang provided 2026 guidance: "We expect revenue to grow 4.7% to 6% compared to prior year... Diagnostics revenue to be up 5% to 6%... BLS revenue to grow 3% to 5%." She indicated margins will rise in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results